FMO5 and fungal infectious disease: Patients having chronic granulomatous disease (CGD), which is caused by a deficiency in the NADPH-oxidase system of phagocytes, making them unable to produce reactive oxygen species, are at high risk having invasive aspergillosis (IA) or other fungal infection.